<DOC>
	<DOCNO>NCT00301665</DOCNO>
	<brief_summary>The purpose study evaluate efficacy botulinum toxin type A ( Dysport® ) injection pericranial muscle compare placebo prevent migraine attack .</brief_summary>
	<brief_title>Efficacy Safety Study Dysport® Used Migraine Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients migraine without aura typical aura define International Headache Society criterion Migraine attack persist 1 year 2 6 migraine attack per month least moderate severity 3 month precede preinclusion visit 2 6 migraine attack least moderate severity screen period Nonmigraine headaches tensiontype headache Migraine prolong aura , familial hemiplegic migraine , basilar migraine , migraine aura without headache , migraine acute onset aura , ophthalmoplegic migraine , retinal migraine , complication migraine Onset migraine age 50 Overuse acute migraine medication ( individual take medication acute migraine 10 day per month ) history drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>